SC
ABMD

Scotia Capital’s Abiomed Inc ABMD Stock Holding History

Scotia Capital’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-2,584
Closed -$716K – 797
2020
Q3 		$716K Buy
+2,584
New +$744K 0.01% 445
2016
Q1 		– Sell
-4,127
Closed -$378K – 876
2015
Q4 		$378K Hold
4,127
– – 0.01% 629
2015
Q3 		$383K Buy
4,127
+428
+12% +$37.7K 0.01% 602
2015
Q2 		$241K Sell
3,699
-1,182
-24% -$78.5K ﹤0.01% 670
2015
Q1 		$349K Buy
+4,881
New +$265K 0.01% 493

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Scotia Capital's ABMD Position: Q4 2020 in Review

Scotia Capital sold out of Abiomed Inc (ABMD) in Q4 2020, closing a stake of 2,584 shares — an estimated $716K sold.

Scotia Capital first reported a position in ABMD in Q1 2015 and held it in 5 quarters. The position peaked at $716K in Q3 2020. 498 funds tracked by Wall St. Rank hold ABMD as of Q4 2020.

  • Scotia Capital reported no remaining Abiomed Inc position as of Q4 2020 after selling out during the quarter.
  • Scotia Capital sold 2,584 Abiomed Inc shares in Q4 2020, an estimated $716K.
  • Scotia Capital first reported a position in Abiomed Inc in Q1 2015 and held it in 5 quarters.
  • Scotia Capital's Abiomed Inc position peaked at $716K in Q3 2020.
  • 498 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2020.

Based on Scotia Capital's 13F filing for Q4 2020, filed 11 Feb 2021.